Historical performance data can support a defensible transfer decision when it demonstrates that the analytical procedure has remained stable under controlled conditions and the receiving laboratory has comparable capability. Inspectors typically look beyond the existence of historical data and examine whether the data are actually relevant to the transfer being performed. Results generated with different instruments, modified procedures, changed reference standards, or significantly different analysts may contribute little to the justification.

The documentation should explain why previous performance remains applicable rather than simply attaching trend reports or validation summaries. Evidence showing consistent system suitability, acceptable intermediate precision, investigation history, analyst qualification, and instrument comparability often carries more weight than a large volume of unrelated historical results. Weak justifications usually rely on statements such as "the method has always performed well" without connecting that history to the specific transfer decision. A concise scientific rationale supported by targeted evidence is generally easier to defend than extensive documentation assembled without a clear purpose.

Inspection findings frequently involve documentation that demonstrates what was done but fails to explain why important decisions were made. Completed protocols, signed reports, and acceptable analytical results do not always provide enough evidence to support scientific judgment. Reviewers often focus on whether critical decisions can be reconstructed months or years after the transfer rather than whether the paperwork is complete.

Particular attention is given to changes made during execution, unexplained deviations from the approved protocol, acceptance criteria that were modified without documented justification, and references to supporting assessments that cannot be traced. Another recurring weakness is inconsistency between the transfer report and underlying laboratory records, leaving reviewers uncertain about which version reflects the actual work performed. Documentation that clearly links risk assessments, technical decisions, deviations, and final conclusions into a coherent record is generally easier to defend than reports that summarize outcomes without explaining the reasoning behind them. Well supported documentation demonstrates that scientific decisions were made deliberately rather than after acceptable results were obtained.

Equivalent instruments do not automatically produce equivalent analytical performance. Laboratories often discover this after a transfer when subtle differences in detector configuration, software processing, column heating, sampling mechanisms, or data acquisition settings influence method behavior despite using the same written procedure.

The decision should be based on whether the equipment difference could reasonably affect critical analytical attributes rather than whether the instrument carries the same manufacturer or model designation. High sensitivity methods, impurity profiling, dissolution testing, and techniques dependent on precise environmental control deserve closer examination because seemingly minor hardware differences can influence reproducibility. Documentation should explain why equipment comparability was considered acceptable or why additional comparative work was performed. Records that simply state the instruments were qualified provide limited support because qualification confirms intended operation, not equivalent analytical performance for a particular procedure. Scientific evaluation of equipment related risk generally provides stronger inspection support than relying solely on qualification status.

A successful method transfer should not be treated as permanent evidence that the analytical procedure will continue to perform as expected under all future conditions. Changes introduced after the original transfer can gradually weaken the assumptions that supported the initial decision, even when no single change appears significant on its own.

Reassessment becomes appropriate when there are recurring atypical results, sustained shifts in method performance, repeated laboratory investigations involving the same procedure, significant equipment replacement, software changes affecting data processing, or modifications to critical reagents and reference standards. Organizational changes such as transferring experienced analysts, consolidating laboratories, or introducing new testing sites can also alter method performance in ways that were not evaluated during the original transfer. Records showing routine monitoring, periodic review of performance trends, and documented evaluation of meaningful changes provide stronger evidence of ongoing control than relying solely on the original transfer package. This demonstrates that continued suitability is being actively verified rather than assumed based on historical success.